| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012118 |
| Receipt No. | R000014166 |
| Scientific Title | Sleep pressure and disordered breathing in resistant hypertension and cardiovascular disease registry |
| Date of disclosure of the study information | 2013/10/25 |
| Last modified on | 2019/03/29 (Ver. 11) |
| Basic information | ||
| Public title | Sleep pressure and disordered breathing in resistant hypertension and cardiovascular disease registry | |
| Acronym | SPREAD Registry | |
| Scientific Title | Sleep pressure and disordered breathing in resistant hypertension and cardiovascular disease registry | |
| Scientific Title:Acronym | SPREAD Registry | |
| Region |
|
|
| Condition | ||
| Condition | Cardiovascular disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to study the relationship between frequency of sleep apnea syndrome and nocturnal hypertension in the patients of refractory hypertensive and cardiovascular disease by using the sphygmomanometers to measure the blood pressure surge due to the nighttime hypoxia. In addition, the aim of this study is to identify the high risk patients and provide them the optimal treatment from these results. The plan is to follow up the cases in this registry including of their baseline data to investigate the causal relationship between the frequency of sleep apnea syndrome and pathologies of blood pressure surge. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Total mortality |
| Key secondary outcomes | Cardiovascular death, Sudden death, Ischemic heart disease, Cerebrovascular disease, De novo arteriosclerosis obliterans, Aortic dissection, heart failure that requires hospitalization, De novo diabetes, De novo atrial fibrillation, and Chronic hemodialysis |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who meet the following criteria:
- Refractory hypertension (Patients under treatment with 3 or more antihypertensive agents with office systolic blood pressure of 130 mmHg or higher, or diastolic blood pressure of 80 mmHg or higher) - Cardiovascular disease - Coronary artrey disease: Patients who have a past history of coronary intervention or coronary artery bypass surgery, or diagnosed with coronary disease and receive the medical treatment. - Heart failure: Patients diagnosed with heart failure and receive the medical treatment. - Sleep apnea syndrome (SAS): Apnea hypopnea index (AHI) >5/hr by polysomnography, or suspected SAS and 3% oxygen desaturation index(ODI) 5 and higher, or current medical treatment for SAS. - Peripheral artery disease: Patients diagnosed by imaging and laboratory tests and treated by physician. - Aorta dissection, aortic aneurysm: Patients diagnosed by imaging and laboratory tests and treated by physician. - Atrial fibrillation: Patients diagnosed by imaging and laboratory tests and treated by electrocardiogram. |
|||
| Key exclusion criteria | - Cerebral vascular disease within 6 months (except for asymptomatic or transient ischemic attack)
Hemodialysis patients Having other severe diseases (cancer, connective tissue disease) Unwillingness to sign an informed consent. Patient him/herself or his/her family uses medical devices (e.g., pacemaker) which are affected by electric waves from mobile-phone. Patients considered as inappropriate to participate in this study by attending physicians. |
|||
| Target sample size | 2000 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Jichi Medical University School of Medicine | ||||||
| Division name | Division of Cardiovascular Medicine, Department of Medicine | ||||||
| Zip code | |||||||
| Address | 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan. | ||||||
| TEL | 0285-58-7344 | ||||||
| kkario@jichi.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Jichi Medical University School of Medicine | ||||||
| Division name | Division of Cardiovascular Medicine, Department of Medicine | ||||||
| Zip code | |||||||
| Address | 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan. | ||||||
| TEL | 0285-58-7344 | ||||||
| Homepage URL | |||||||
| spread@jichi.ac.jp | |||||||
| Sponsor | |
| Institute | Jichi Medical University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Sleep and Circadian Cardiology, Jichi Medical University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 自治医科大学
鷲谷病院 国立国際医療研究センター病院 三菱三原病院 宗像市国保大島診療所 聖マリアンナ医科大学 九州大学病院 遠賀中間医師会おんが病院 昭和大学 長岡赤十字病院 大阪暁明館病院 聖路加国際病院 高橋医院 大阪府済生会富田林病院 宮下内科クリニック 天理よろづ相談所病院 沖縄県立中部病院 近内科クリニック 小竹町立病院 徳山医師会病院 田中内科医院 順天堂大学医学部附属 順天堂医院 京都府立医科大学大学院医学研究科 オムロンヘルスケア株式会社 オムロン株式会社 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014166 |